Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Fearful Fed, rising crude and more... - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Jun 17, 2008

    Fearful Fed, rising crude and more...

    Interest rates on the rise
    The Fed Reserve is in a quandary. Fearful of a recession in the US, which was fuelled by one of the worst financial crisis in the world namely the subprime meltdown, the Fed Reserve went on an interest rate cutting spree in the hope that consumers would have more income to spend; incomes being eroded due to falling house prices and rising unemployment. However, since then, rising commodity prices and high inflation rates have posed a serious dilemma to the US Fed, which will most likely halt the interest rate cuts, if not effect an increase. And US is not the only country at the receiving end; inflation is hurting other countries too both in the developed as well the developing world.

    While the European Central Bank (ECB) has hinted at the possibility of a rate hike, the developing world primarily China and India have also followed suit. While China has raised the amount of reserves banks must hold against their loans, the Central Bank of India, Reserve Bank of India.(RBI), too has been compelled to raise the repo rate to 8%. Brazil, Russia, Indonesia and the Philippines have also increased rates. This has cast a pall of gloom over the investing community, who fear diminishing corporate earnings and slowdown in growth, a sentiment, which has been reflected in the weakness prevailing across major stockmarket indices around the world.

  • The poorer Rupee

    Daiichi-Ranbaxy deal to set an example?
    Japanese drug maker Daiichi Sankyo acquiring majority stake in Indian pharma company Ranbaxy has been touted as one of the biggest deals in the global pharma space. Besides the fact that both are big and established companies in their respective countries; Daiichi is the third largest pharma company in Japan, while Ranbaxy is India's largest pharma company, the price that Daiichi has paid - a mammoth US$ 4.6 bn - underlines how large this deal is. Infact, this deal is likely to set the trend for other global innovator pharma companies to follow suit.

    A declining pipeline of drugs, fewer new drug approvals and impending patent expirations continue to mar the financial performance of innovator companies. Their problems are compounded further by the fact that generic companies are becoming more and more aggressive in challenging patents, which has caused legal costs to spiral. Many of them have also entered into settlement agreements with generic companies, and by making payments have ensured that the latter launch the drug only close to the date on which the patent is set to expire. In such a challenging scenario, innovator companies acquiring generic companies cannot be ruled out. This is despite innovators being reluctant to associate themselves with generic companies owing to thin profit margins of the latter. At present, Novartis is the only company, which has been able to have the best of both worlds; while the company is among the top 5 pharma companies in the world, its generic arm Sandoz is the second largest generics company in the world.

  • Ranbaxy sells out to Daiichi: Our view

    Is there an end to rising oil prices?
    Not too soon, says Morgan Stanley through its Global Economic Forum. Until recently, the spike in oil prices was demand driven as emerging economies' (primarily India and China) thirst for oil was unquenchable. Morgan Stanley states "the two most recent spikes in crude oil prices, from US$ 100 per barrel to US$ 125 in early May, then from US$ 128 to close to US$ 140 in early June, are pointing to structural changes in the oil market, which is suggesting that we are now facing a genuine supply-side shock. The nuance is important because a supply-side shock is by nature contractionary for the global economy, in contrast with a demand-driven change, where strong economic expansion is inflating input prices".

    It further states that non-OPEC producing countries having likely reached peak production and geopolitical issues in the Middle East are two major reasons supporting the premise of a supply-induced shock. Particularly, the recent tensions between Iran and Israel have brought to the fore the possibility that there is not enough global spare capacity to extract oil, with OPEC nations seemingly reluctant to increase output and non-OPEC production having stagnated. No wonder than, that Saudi Arabia's decision to raise production by 500,000 barrels per day was greeted with much cheer sending the global stockmarket indices on an upward path.

  • High crude prices: Will they last?



    Equitymaster requests your view! Post a comment on "Fearful Fed, rising crude and more...". Click here!


    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    Were You Lured By Mr Market's Bait? (The 5 Minute Wrapup)

    Aug 23, 2017

    Mr Market lured investors into believing they'd bitten into a crash. Did you take the bait?

    Deep State First (Vivek Kaul's Diary)

    Aug 23, 2017

    Nowhere was the darkness deeper than in the nation's capital. There, no light shone. No flicker of awareness...observation...learning...or reflection appeared.

    Why Hasn't Warren Buffett Rung the Bell Yet? (The 5 Minute Wrapup)

    Aug 22, 2017

    It's surprising Warren Buffett hasn't warned investors about the expensive stock market? Let us know why.

    Think Twice Before You Keep Money In A Savings Bank Account (Outside View)

    Aug 22, 2017

    Post demonetisation, a cut in bank savings deposits rates was in the offing.

    More Views on News

    Most Popular

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

    Aug 21, 2017

    Most Indians who cannot find jobs, look at becoming self-employed.

    It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

    Aug 16, 2017

    The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

    Aug 22, 2017

    Post demonetisation, a cut in bank savings deposits rates was in the offing.

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 23, 2017 (Close)